Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis

Journal of Biological Chemistry

Volumn 288, Issue 52, 2013, Pages 37319-37331

  Chung, Hyunjae ^a   Ramachandran, Rithwik ^a   Hollenberg, Morley D ^a   Muruve, Daniel A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; CONNECTIVE TISSUE GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTORS; PROTEINASE-ACTIVATED RECEPTOR; RECEPTOR SIGNALING; THERAPEUTIC TARGETS; TRANSACTIVATION; TRANSFORMING GROWTH FACTORS;

COLLAGEN; MUSCULOSKELETAL SYSTEM;

GENE EXPRESSION;

ALPHA SMOOTH MUSCLE ACTIN; CONNECTIVE TISSUE GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; UPREGULATION;

EID: 84891387754     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.492793     Document Type: Article

References (51)

1. Ali, T., Khan, I., Simpson, W., Prescott, G., Townend, J., Smith, W., and Macleod, A. (2007) Incidence and outcomes in acute kidney injury. A comprehensive population-based study. J. Am. Soc. Nephrol. 18, 1292-1298
2. Eddy, A. A. (2000) Molecular basis of renal fibrosis. Pediatr. Nephrol. 15, 290-301
3. Eddy, A. A. (2009) Serine proteases, inhibitors and receptors in renal fibrosis. Thromb. Haemost. 101, 656-664
4. Ramachandran, R., Noorbakhsh, F., Defea, K., and Hollenberg, M. D. (2012) Targeting proteinase-activated receptors. Therapeutic potential and challenges. Nat. Rev. Drug Discov. 11, 69-86
5. Rothmeier, A. S., and Ruf, W. (2012) Protease-activated receptor 2 signaling in inflammation. Semin. Immunopathol. 34, 133-149
6. Hyun, E., Andrade-Gordon, P., Steinhoff, M., and Vergnolle, N. (2008) Protease-activated receptor-2 activation. A major actor in intestinal inflammation. Gut 57, 1222-1229
7. Cenac, N., Coelho, A. M., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W. K., Wallace, J. L., Hollenberg, M. D., Bunnett, N. W., Garcia-Villar, R., Bueno, L., and Vergnolle, N. (2002) Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161, 1903-1915
8. Lindner, J. R., Kahn, M. L., Coughlin, S. R., Sambrano, G. R., Schauble, E., Bernstein, D., Foy, D., Hafezi-Moghadam, A., and Ley, K. (2000) Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J. Immunol. 165, 6504-6510
9. Gui, Y., Loutzenhiser, R., and Hollenberg, M. D. (2003) Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney. Am. J. Physiol. Renal Physiol. 285, F95-F104
10. Morla, L., Brideau, G., Fila, M., Crambert, G., Cheval, L., Houillier, P., Ramakrishnan, S., Imbert-Teboul, M., and Doucet, A. (2013) Renal proteinase-activated receptor 2, a new actor in the control of blood pressure and plasma potassium level. J. Biol. Chem. 288, 10124-10131
11. Vesey, D. A., Kruger, W. A., Poronnik, P., Gobé, G. C., and Johnson, D. W. (2007) Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation. Am. J. Physiol. Renal Physiol. 293, F1441-F1449
12. Knight, V., Tchongue, J., Lourensz, D., Tipping, P., and Sievert, W. (2012) Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells. Hepatology 55, 879-887
13. Frungieri, M. B., Weidinger, S., Meineke, V., Köhn, F. M., and Mayerhofer, A. (2002) Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ. Possible relevance to human fibrotic disorders. Proc. Natl. Acad. Sci. U.S.A. 99, 15072-15077
14. Su, X., and Matthay, M. A. (2009) Role of protease-activated receptor 2 in experimental acute lung injury and lung fibrosis. Anat. Rec. (Hoboken) 292, 580-586
15. Damiano, B. P., Cheung, W. M., Santulli, R. J., Fung-Leung, W. P., Ngo, K., Ye, R. D., Darrow, A. L., Derian, C. K., de Garavilla, L., and Andrade-Gordon, P. (1999) Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J. Pharmacol. Exp. Ther 288, 671-678
16. White, L. R., Blanchette, J. B., Ren, L., Awn, A., Trpkov, K., and Muruve, D. A. (2007) The characterization of α5-integrin expression on tubular epithelium during renal injury. Am. J. Physiol. Renal Physiol. 292, F567-576
17. Wuthrich, R. P., Glimcher, L. H., Yui, M. A., Jevnikar, A. M., Dumas, S. E., and Kelley, V. E. (1990) MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int. 37, 783-792
18. Ramachandran, R., Mihara, K., Chung, H., Renaux, B., Lau, C. S., Muruve, D. A., DeFea, K. A., Bouvier, M., and Hollenberg, M. D. (2011) Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2). J. Biol. Chem. 286, 24638-24648
19. Al-Ani, B., Saifeddine, M., Kawabata, A., Renaux, B., Mokashi, S., and Hollenberg, M. D. (1999) Proteinase-activated receptor 2 (PAR(2)). Development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands. J. Pharmacol. Exp. Ther. 290, 753-760
20. Kondo, S., Kagami, S., Kido, H., Strutz, F., Müller, G. A., and Kuroda, Y. (2001) Role of mast cell tryptase in renal interstitial fibrosis. J. Am. Soc. Nephrol. 12, 1668-1676
21. Lan, H. Y. (2011) Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int. J. Biol. Sci. 7, 1056-1067
22. Schäfer, B., Gschwind, A., and Ullrich, A. (2004) Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23, 991-999
23. Yu, Q., and Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-176
24. Li, J. H., Huang, X. R., Zhu, H. J., Oldfield, M., Cooper, M., Truong, L. D., Johnson, R. J., and Lan, H. Y. (2004) Advanced glycation end products activate Smad signaling via TGF-β-dependent and independent mechanisms. Implications for diabetic renal and vascular disease. FASEB J. 18, 176-178
25. Hao, J., Wang, B., Jones, S. C., Jassal, D. S., and Dixon, I. M. (2000) Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am. J. Physiol. Heart Circ. Physiol. 279, H3020-3030
26. Kalmes, A., Daum, G., and Clowes, A. W. (2001) EGFR transactivation in the regulation of SMC function. Ann. N.Y. Acad. Sci. 947, 42-54; discussion 54-45
27. Zhang, Q., Thomas, S. M., Lui, V. W., Xi, S., Siegfried, J. M., Fan, H., Smithgall, T. E., Mills, G. B., and Grandis, J. R. (2006) Phosphorylation of TNF-α converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. Proc. Natl. Acad. Sci. U.S.A. 103, 6901-6906
28. Gschwind, A., Zwick, E., Prenzel, N., Leserer, M., and Ullrich, A. (2001) Cell communication networks. Epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20, 1594-1600
29. Xiong, J., Zhu, Z., Liu, J., Wang, Y., and Li, Z. (2005) Role of protease activated receptor-2 expression in renal interstitial fibrosis model in mice. J. Huazhong Univ. Sci. Technolog. Med. Sci. 25, 523-526
30. Grandaliano, G., Pontrelli, P., Cerullo, G., Monno, R., Ranieri, E., Ursi, M., Loverre, A., Gesualdo, L., and Schena, F. P. (2003) Protease-activated receptor-2 expression in IgA nephropathy. A potential role in the pathogenesis of interstitial fibrosis. J. Am. Soc. Nephrol. 14, 2072-2083
31. Okuno, M., Akita, K., Moriwaki, H., Kawada, N., Ikeda, K., Kaneda, K., Suzuki, Y., and Kojima, S. (2001) Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-β. Gastroenterology 120, 1784-1800
32. Ishikura, H., Nishimura, S., Matsunami, M., Tsujiuchi, T., Ishiki, T., Sekiguchi, F., Naruse, M., Nakatani, T., Kamanaka, Y., and Kawabata, A. (2007) The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents. Life Sci. 80, 1999-2004
33. Maekawa, A., Kakizoe, Y., Miyoshi, T., Wakida, N., Ko, T., Shiraishi, N., Adachi, M., Tomita, K., and Kitamura, K. (2009) Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in saltsensitive hypertension. J. Hypertens. 27, 181-189
34. Morinaga, J., Kakizoe, Y., Miyoshi, T., Onoue, T., Ueda, M., Mizumoto, T., Yamazoe, R., Uchimura, K., Hayata, M., Shiraishi, N., Adachi, M., Sakai, Y., Tomita, K., and Kitamura, K. (2013) The anti-fibrotic effect of a serine protease inhibitor in the kidney. Am. J. Physiol. Renal Physiol. 305, F173-F181
35. Katoh, H., Ishikawa, H., Hasegawa, M., Yoshida, Y., Suzuki, Y., Ohno, T., Takahashi, T., and Nakano, T. (2010) Protective effect of urinary trypsin inhibitor on the development of radiation-induced lung fibrosis in mice. J. Radiat. Res. 51, 325-332
36. Kono, T., Kashiwade, Y., Asama, T., Chisato, N., Ebisawa, Y., Yoneda, M., and Kasai, S. (2011) Preventive effect of urinary trypsin inhibitor on the development of liver fibrosis in mice. Exp. Biol. Med. (Maywood) 236, 1314-1321
37. Ramachandran, R., and Hollenberg, M. D. (2008) Proteinases and signalling. Pathophysiological and therapeutic implications via PARs and more. Br. J. Pharmacol. 153, S263-282
38. Liu, H., Liu, F., Peng, Y., Liu, Y., Li, L., Tu, X., Cheng, M., Xu, X., Chen, X., Ling, G., and Sun, L. (2010) Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy. Inflamm. Res. 59, 551-559
39. Borensztajn, K., Stiekema, J., Nijmeijer, S., Reitsma, P. H., Peppelenbosch, M. P., and Spek, C. A. (2008) Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am. J. Pathol. 172, 309-320
40. Murray, D. B., McLarty-Williams, J., Nagalla, K. T., and Janicki, J. S. (2012) Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2). J. Cell Commun. Signal. 6, 45-51
41. Compton, S. J., Renaux, B., Wijesuriya, S. J., and Hollenberg, M. D. (2001) Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase. Br. J. Pharmacol. 134, 705-718
42. Schnaper, H. W., Hayashida, T., and Poncelet, A. C. (2002) It's a Smad world. Regulation of TGF-β signaling in the kidney. J. Am. Soc. Nephrol. 13, 1126-1128
43. Burch, M. L., Ballinger, M. L., Yang, S. N., Getachew, R., Itman, C., Loveland, K., Osman, N., and Little, P. J. (2010) Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by proteaseactivated receptor-1 transactivation of the transforming growth factor β type I receptor. J. Biol. Chem. 285, 26798-26805
44. Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., and Ullrich, A. (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884-888
45. Darmoul, D., Gratio, V., Devaud, H., and Laburthe, M. (2004) Proteaseactivated receptor 2 in colon cancer. Trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J. Biol. Chem. 279, 20927-20934
46. Chen, J., Chen, J. K., and Harris, R. C. (2012) Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury. Kidney Int. 82, 45-52
47. Tang, J., Liu, N., Tolbert, E., Ponnusamy, M., Ma, L., Gong, R., Bayliss, G., Yan, H., and Zhuang, S. (2013) Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury. Am. J. Pathol. 183, 160-172
48. Andreev, J., Galisteo, M. L., Kranenburg, O., Logan, S. K., Chiu, E. S., Okigaki, M., Cary, L. A., Moolenaar, W. H., and Schlessinger, J. (2001) Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J. Biol. Chem. 276, 20130-20135
49. Gore-Hyer, E., Shegogue, D., Markiewicz, M., Lo, S., Hazen-Martin, D., Greene, E. L., Grotendorst, G., and Trojanowska, M. (2002) TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am. J. Physiol. Renal Physiol. 283, F707-F716
50. Zhang, C., Meng, X., Zhu, Z., Liu, J., and Deng, A. (2004) Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro. Cell Biol. Int. 28, 863-873
51. Phanish, M. K., Wahab, N. A., Colville-Nash, P., Hendry, B. M., and Dockrell, M. E. (2006) The differential role of Smad2 and Smad3 in the regulation of pro-fibroticTGFβ1 responses in human proximal-tubule epithelial cells. Biochem. J. 393, 601-607